Chordia Therapeutics Inc. (TYO:190A)
Japan · Delayed Price · Currency is JPY 99.00
-2.00 (-1.98%)
Jun 4, 2026, 3:30 PM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 7.3 billion as of June 4, 2026. Its market cap has decreased by -53.80% in one year.
Market Cap
7.30B
Enterprise Value
4.85B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
99.00
Market Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 7.30B, a decrease of -42.00%. That is a compound annual growth rate of -24.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 7.30B | -2.03% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
| Jun 14, 2024 | 12.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cawachi | 73.93B |
| Qol Holdings | 69.14B |
| Shinnihonseiyaku | 39.33B |
| Heartseed | 35.80B |
| YAKUODO HOLDINGS | 31.49B |
| Astena Holdings | 19.37B |
| Medical System Network | 14.94B |
| Ohki Healthcare Holdings | 14.57B |